Skip to main content
Top
Published in: Abdominal Radiology 2/2010

01-04-2010 | Invited Feature Section

Pancreatic adenocarcinoma versus chronic pancreatitis: differentiation with triple-phase helical CT

Authors: Yasunari Yamada, Hiromu Mori, Shunro Matsumoto, Hiro Kiyosue, Yuko Hori, Norio Hongo

Published in: Abdominal Radiology | Issue 2/2010

Login to get access

Abstract

Background

Chronic pancreatitis and pancreatic adenocarcinoma often show similar clinical and imaging appearances. This study aims to differentiate chronic pancreatitis from pancreatic adenocarcinoma by defining enhancement patterns in both pathologic conditions during triple-phase helical CT.

Methods

The study included 42 patients with chronic pancreatitis and 85 patients with pancreatic adenocarcinoma. CT images obtained according to protocol A (scan delays, 30, 60, and 150 s; 300 mg I/mL contrast material) or protocol B (scan delays, 40, 70, and 150 s; 370 mg I/mL contrast material) were retrospectively evaluated.

Results

Mean contrast enhancement value of normal pancreas peaked in the first phase (early-washout pattern) while that of chronic pancreatitis peaked in the second phase (delayed-washout pattern), and that of pancreatic adenocarcinoma gradually rose (increasing pattern) in both protocols. Diagnostic indices for pancreatic adenocarcinoma were 82.4% and 94.1% for sensitivity, 83% and 83% for specificity, 82.7% and 90.4% for accuracy in protocols A and B, respectively, when differentiation between chronic pancreatitis and pancreatic adenocarcinoma was performed based on time-attenuation curve patterns.

Conclusion

Our results indicate that time attenuation curves obtained from triple-phase helical CT in protocol B provide useful information in differentiating chronic pancreatitis from pancreatic adenocarcinoma.
Literature
1.
go back to reference Chijiwa K, Saiki S, et al. (1996) “Mass-forming” pancreatitis masquerades as pancreatic carcinoma. Int J Pancreatol 20:27–35 Chijiwa K, Saiki S, et al. (1996) “Mass-forming” pancreatitis masquerades as pancreatic carcinoma. Int J Pancreatol 20:27–35
3.
go back to reference Bramhall SR, Allum WH, Jones AG, et al. (1995) Treatment and survival in 13, 560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 82:111–115CrossRefPubMed Bramhall SR, Allum WH, Jones AG, et al. (1995) Treatment and survival in 13, 560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 82:111–115CrossRefPubMed
4.
go back to reference Smith CD, Behrns KE, van Heerden JA, et al. (1994) Radical pancreatoduodenectomy for misdiagnosed pancreatic mass. Br J Surg 81:585–589CrossRefPubMed Smith CD, Behrns KE, van Heerden JA, et al. (1994) Radical pancreatoduodenectomy for misdiagnosed pancreatic mass. Br J Surg 81:585–589CrossRefPubMed
5.
go back to reference Tajima Y, Kuroki T, Tsutsumi R, Kim T, et al. (2007) Pancreatic carcinoma coexisting with chronic pancreatitis versus tumor-forming pancreatitis: diagnostic utility of the time-signal intensity curve from dynamic contrast-enhanced MR imaging. World J Gastroenterol 13:858–865PubMed Tajima Y, Kuroki T, Tsutsumi R, Kim T, et al. (2007) Pancreatic carcinoma coexisting with chronic pancreatitis versus tumor-forming pancreatitis: diagnostic utility of the time-signal intensity curve from dynamic contrast-enhanced MR imaging. World J Gastroenterol 13:858–865PubMed
6.
go back to reference Kim JK, Altun E, Elias J, et al. (2007) Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI. J Magn Reson Imaging 26:313–322CrossRefPubMed Kim JK, Altun E, Elias J, et al. (2007) Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI. J Magn Reson Imaging 26:313–322CrossRefPubMed
7.
go back to reference Ichikawa T, Sou H, Araki T, et al. (2001) Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 221:107–116CrossRefPubMed Ichikawa T, Sou H, Araki T, et al. (2001) Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 221:107–116CrossRefPubMed
8.
go back to reference Lu DSK, Vedantham S, Krasney RM, et al. (1996) Two-phase helical CT for pancreatic tumors: pancreatic and hepatic phase enhancement of tumor, pancreas and vascular structures. Radiology 199:697–701PubMed Lu DSK, Vedantham S, Krasney RM, et al. (1996) Two-phase helical CT for pancreatic tumors: pancreatic and hepatic phase enhancement of tumor, pancreas and vascular structures. Radiology 199:697–701PubMed
9.
go back to reference Fletcher JG, Wiersema MJ, Farrel MA, et al. (2003) Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology 229:81–90CrossRefPubMed Fletcher JG, Wiersema MJ, Farrel MA, et al. (2003) Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology 229:81–90CrossRefPubMed
10.
go back to reference Zeman RK, Silverman PM, Ascher SM, et al. (1995) Helical (spiral) CT of the pancreas and biliary tract. Radiol Clin North Am 33:887–902PubMed Zeman RK, Silverman PM, Ascher SM, et al. (1995) Helical (spiral) CT of the pancreas and biliary tract. Radiol Clin North Am 33:887–902PubMed
11.
go back to reference Tublin ME, Tessler FN, Cheng AL, et al. (1999) Effect of injection rate of contrast medium on pancreatic and hepatic helical CT. Radiology 210:97–101PubMed Tublin ME, Tessler FN, Cheng AL, et al. (1999) Effect of injection rate of contrast medium on pancreatic and hepatic helical CT. Radiology 210:97–101PubMed
12.
go back to reference Schlieman MG, Ho HS, Bold RJ (2003) Utility of tumor markers in determining resectability of pancreatic cancer. Arch Surg 138:951–955CrossRefPubMed Schlieman MG, Ho HS, Bold RJ (2003) Utility of tumor markers in determining resectability of pancreatic cancer. Arch Surg 138:951–955CrossRefPubMed
13.
go back to reference Yoshida K, Toki F, Takeuchi T, et al. (1995) Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561–1568CrossRefPubMed Yoshida K, Toki F, Takeuchi T, et al. (1995) Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561–1568CrossRefPubMed
14.
go back to reference Okazaki K, Uchida K, Ohara M, et al. (2000) Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 118:573–581CrossRefPubMed Okazaki K, Uchida K, Ohara M, et al. (2000) Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 118:573–581CrossRefPubMed
15.
go back to reference Yang DH, Kim KW, Kim TK, et al. (2006) Autoimmune pancreatitis: radiologic findings in 20 patients. Abdom Imaging 31:94–102CrossRefPubMed Yang DH, Kim KW, Kim TK, et al. (2006) Autoimmune pancreatitis: radiologic findings in 20 patients. Abdom Imaging 31:94–102CrossRefPubMed
16.
go back to reference Bluemke DA, Cameron JL, Hruban RH, et al. (1995) Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 197:381–385PubMed Bluemke DA, Cameron JL, Hruban RH, et al. (1995) Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 197:381–385PubMed
17.
go back to reference Diehl S, Lehmann K, Sadick M, et al. (1998) Pancreatic cancer: value of dual-phase helical CT in assessing respectability. Radiology 206:373–378PubMed Diehl S, Lehmann K, Sadick M, et al. (1998) Pancreatic cancer: value of dual-phase helical CT in assessing respectability. Radiology 206:373–378PubMed
18.
go back to reference Tabuchi T, Itoh K, Ohshio G, et al. (1999) Tumor staging of pancreatic adenocarcinoma using early and late-phase helical CT. AJR Am J Roentgenol 173:375–380PubMed Tabuchi T, Itoh K, Ohshio G, et al. (1999) Tumor staging of pancreatic adenocarcinoma using early and late-phase helical CT. AJR Am J Roentgenol 173:375–380PubMed
19.
go back to reference Vargas R, Nino-Murcia M, Trueblood W, et al. (2004) MDCT in pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. AJR Am J Roentgenol 182:419–425PubMed Vargas R, Nino-Murcia M, Trueblood W, et al. (2004) MDCT in pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. AJR Am J Roentgenol 182:419–425PubMed
20.
go back to reference Kim T, Murakami T, Takamura M, et al. (2001) Pancreatic mass due to chronic pancreatitis: correlation of CT and MR imaging features with pathologic findings. AJR Am J Roentgenol 177:367–371PubMed Kim T, Murakami T, Takamura M, et al. (2001) Pancreatic mass due to chronic pancreatitis: correlation of CT and MR imaging features with pathologic findings. AJR Am J Roentgenol 177:367–371PubMed
21.
go back to reference Furukawa H, Takayasu K, Mukai K, et al. (1996) Late contrast-enhanced CT for small pancreatic carcinoma: delayed enhanced area on CT with histopathological correlation. Hepatogastroenterology 43:1230–1237PubMed Furukawa H, Takayasu K, Mukai K, et al. (1996) Late contrast-enhanced CT for small pancreatic carcinoma: delayed enhanced area on CT with histopathological correlation. Hepatogastroenterology 43:1230–1237PubMed
22.
go back to reference Demachi H, Matsui O, Kobayashi S, et al. (1997) Histological influence on contrast-enhanced CT of pancreatic ductal adenocarcinoma. J Comput Assist Tomogr 21:980–985CrossRefPubMed Demachi H, Matsui O, Kobayashi S, et al. (1997) Histological influence on contrast-enhanced CT of pancreatic ductal adenocarcinoma. J Comput Assist Tomogr 21:980–985CrossRefPubMed
23.
go back to reference Kim T, Murakami T, Takahashi S, et al. (1998) Effect of injection rates of contrast material on arterial phase hepatic CT. AJR Am J Roentgenol 171:429–432PubMed Kim T, Murakami T, Takahashi S, et al. (1998) Effect of injection rates of contrast material on arterial phase hepatic CT. AJR Am J Roentgenol 171:429–432PubMed
24.
go back to reference Awai K, Hori S (2003) Effect of contrast injection protocol with dose tailored to patient weight and fixed injection duration on aortic and hepatic enhancement at multidetector-row helical CT. Eur Radiol 13:2155–2160CrossRefPubMed Awai K, Hori S (2003) Effect of contrast injection protocol with dose tailored to patient weight and fixed injection duration on aortic and hepatic enhancement at multidetector-row helical CT. Eur Radiol 13:2155–2160CrossRefPubMed
25.
go back to reference Itoh S, Satake H, Ohta T, et al. (2002) Pancreatic ductal adenocarcinoma showing iso-attenuation in early-phase contrast-enhanced CT: comparison with histopathological findings. Radiat Med 20:59–67PubMed Itoh S, Satake H, Ohta T, et al. (2002) Pancreatic ductal adenocarcinoma showing iso-attenuation in early-phase contrast-enhanced CT: comparison with histopathological findings. Radiat Med 20:59–67PubMed
26.
go back to reference Boland GW, O’Malley ME, Saez M, et al. (1999) Pancreatic-phase versus portal vein-phase helical CT of the pancreas: optimal temporal window for evaluation of pancreatic adenocarcinoma. AJR Am J Roentgenol 172:605–608PubMed Boland GW, O’Malley ME, Saez M, et al. (1999) Pancreatic-phase versus portal vein-phase helical CT of the pancreas: optimal temporal window for evaluation of pancreatic adenocarcinoma. AJR Am J Roentgenol 172:605–608PubMed
27.
go back to reference McNulty NJ, Francis IR, Platt JF, et al. (2001) Multi-detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology 220:97–102PubMed McNulty NJ, Francis IR, Platt JF, et al. (2001) Multi-detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology 220:97–102PubMed
28.
go back to reference Tajima Y, Matsuzaki S, Furui J, et al. (2004) Use of the time-signal intensity curve from dynamic magnetic resonance imaging to evaluate remnant pancreatic fibrosis after pancreaticojejunostomy in patients undergoing pancreaticoduodenectomy. Br J Surg 91:595–600CrossRefPubMed Tajima Y, Matsuzaki S, Furui J, et al. (2004) Use of the time-signal intensity curve from dynamic magnetic resonance imaging to evaluate remnant pancreatic fibrosis after pancreaticojejunostomy in patients undergoing pancreaticoduodenectomy. Br J Surg 91:595–600CrossRefPubMed
29.
go back to reference Cubilla AL, Fitzgerald PJ (1984) Tumors of the exocrine pancreas. In: Atlas of tumor pathology. 2nd ed, vol 19, Washington, DC: Armed Forces Institute of Pathology, pp 1–40 Cubilla AL, Fitzgerald PJ (1984) Tumors of the exocrine pancreas. In: Atlas of tumor pathology. 2nd ed, vol 19, Washington, DC: Armed Forces Institute of Pathology, pp 1–40
30.
go back to reference Kuniyasu H, Abburuzzese JL, Cleary KR, et al. (2001) Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma. Int J Oncol 19:681–685PubMed Kuniyasu H, Abburuzzese JL, Cleary KR, et al. (2001) Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma. Int J Oncol 19:681–685PubMed
31.
go back to reference De Angelis C, Valente G, Spaccapietra M, et al. (1992) Histological study of alcoholic, nonalcoholic, and obstructive chronic pancreatitis. Pancreas 7:193–196PubMedCrossRef De Angelis C, Valente G, Spaccapietra M, et al. (1992) Histological study of alcoholic, nonalcoholic, and obstructive chronic pancreatitis. Pancreas 7:193–196PubMedCrossRef
32.
go back to reference Schilling MK, Redaelli C, Reber PU, et al. (1999) Microcirculation in chronic pancreatitis: a laser Doppler flow study. Pancreas 19:21–25CrossRefPubMed Schilling MK, Redaelli C, Reber PU, et al. (1999) Microcirculation in chronic pancreatitis: a laser Doppler flow study. Pancreas 19:21–25CrossRefPubMed
33.
go back to reference Lewis MP, Lo SK, Reber PU, et al. (2000) Endoscopic measurement of pancreatic tissue perfusion in patients with chronic pancreatitis and control patients. Gastrointest Endosc 51:195–199CrossRefPubMed Lewis MP, Lo SK, Reber PU, et al. (2000) Endoscopic measurement of pancreatic tissue perfusion in patients with chronic pancreatitis and control patients. Gastrointest Endosc 51:195–199CrossRefPubMed
34.
go back to reference Tsuda T, Mochizuki T, Kikuchi K, et al. (2001) Late-phase enhancement of the upstream portion of pancreatic adenocarcinoma on dual-phase helical CT. Abdom Imaging 26:635–639CrossRefPubMed Tsuda T, Mochizuki T, Kikuchi K, et al. (2001) Late-phase enhancement of the upstream portion of pancreatic adenocarcinoma on dual-phase helical CT. Abdom Imaging 26:635–639CrossRefPubMed
Metadata
Title
Pancreatic adenocarcinoma versus chronic pancreatitis: differentiation with triple-phase helical CT
Authors
Yasunari Yamada
Hiromu Mori
Shunro Matsumoto
Hiro Kiyosue
Yuko Hori
Norio Hongo
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 2/2010
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-009-9579-7

Other articles of this Issue 2/2010

Abdominal Radiology 2/2010 Go to the issue

EditorialNotes

Introduction

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine